PlainRecalls
FDA Drug Critical Class I Terminated

Blue Fusion Capsules, 1- count blister pack, Distributed by: DNS Distribution 5225 Canyon Crest Dr. Ste 71-640, Riverside, CA 92507, UPC 7 48252 66460 0

Reported: April 3, 2019 Initiated: March 14, 2019 #D-1085-2019

Product Description

Blue Fusion Capsules, 1- count blister pack, Distributed by: DNS Distribution 5225 Canyon Crest Dr. Ste 71-640, Riverside, CA 92507, UPC 7 48252 66460 0

Reason for Recall

Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared ingredients: Sildenafil, Tadalafil, desmethyl carbodenafil, dithiodesmethyl carbodenafil, scutellarin, and daidzein.

Details

Recalling Firm
Ata International Inc
Units Affected
Unknown
Distribution
Nationwide within the United States
Location
Orange, CA

Frequently Asked Questions

What product was recalled?
Blue Fusion Capsules, 1- count blister pack, Distributed by: DNS Distribution 5225 Canyon Crest Dr. Ste 71-640, Riverside, CA 92507, UPC 7 48252 66460 0. Recalled by Ata International Inc. Units affected: Unknown.
Why was this product recalled?
Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared ingredients: Sildenafil, Tadalafil, desmethyl carbodenafil, dithiodesmethyl carbodenafil, scutellarin, and daidzein.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 3, 2019. Severity: Critical. Recall number: D-1085-2019.